Genotyping Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market growth.

WILMINGTON, Del., Feb. 16, 2026 /PRNewswire/ — Allied Market Research published a report, titled, “Genotyping Market by Product (Instruments, Reagents and Kits and Software and Services), Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the genotyping market was valued at $16.8 billion in 2023, and is estimated to reach $61.6 billion by 2033, growing at a CAGR of 13.8% from 2024 to 2033.

Prime determinants of growth  

The surge in prevalence of genetic disorders worldwide, such as cancer, cardiovascular diseases, and neurological disorders, shift towards personalized medicine, and increase in demand for forensic DNA analysis are the major factors that drive the growth of the genotyping market. However, the high cost of genotyping technologies restricts market growth. Moreover, advancements in genomic research offers remunerative opportunities for the expansion of the global genotyping market.  

Request Sample of the Report on Global Genotyping Market 2033 – https://www.alliedmarketresearch.com/request-sample/840

Report coverage & details

In research and population genomics, scientists use genotyping to study genetic associations with disease susceptibility, behavioral traits, and evolutionary patterns. These insights help drive preventive public health strategies and research efforts aimed at understanding disease mechanisms.

Genotyping also extends beyond human health. In agriculture and animal breeding, genotyping identifies desirable traits in crops and livestock. Plant breeders use genotyping to select for disease resistance, higher yield, and tolerance to environmental stress. Similarly, livestock genotyping supports traits such as growth rate, fertility, and product quality. These applications enhance productivity, sustainability, and food security.

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/840

Segment Highlights  

The reagents and kits segment dominated the market share in 2023

By product, the reagents and kits segment dominated the market share in 2023. This is attributed to increase in adoption of genotyping technologies across research, diagnostics, agriculture, and forensic science. In addition, advancements in genotyping platforms and techniques require specialized reagents and kits tailored to specific applications. This enhances the growth of the genotyping market.

The diagnostics and personalized medicine segment dominated the market share in 2023

By application, the diagnostics and personalized medicine segment dominated the market share in 2023. This is attributed to increase in demand for genetic testing and tailored treatment approaches and the shift towards personalized medicine. In addition, the rise in prevalence of genetic disorders and the surge in emphasis on preventive healthcare contribute to the growth of the segment. The diagnostics and personalized medicine segment is expected to experience growth with ongoing technological advancements and expanding applications in healthcare. 

The diagnostics and research laboratories segment dominated the market share in 2023

By end user, the diagnostics and research laboratories segment dominated the market share in 2023. This is attributed to increase in demand for genotyping assays in clinical diagnostics, disease screening, and personalized medicine. Research laboratories continue to drive innovation in genomics research, drug discovery, and agricultural biotechnology, contributing to the expansion of the genotyping market. In addition, advancements in genotyping technologies and bioinformatics tools enhance the capabilities of diagnostics and research laboratories to analyze genetic data accurately and efficiently thereby propelling the segment growth.

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/840

North America to maintain its dominance by 2033

North America is poised to maintain its leadership status in the genotyping market during the forecast period owing to robust investments in research and development, advanced healthcare infrastructure, and a strong regulatory framework supporting genetic technologies. The presence of major market players and academic institutions further fosters the growth of the market in North America.

Key Players

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Agilent Technologies Inc
• Eurofins Genomics LLC
• Bio-Rad Laboratories Inc.
• PacBio
• Integrated DNA Technologies Inc.

Why Is Demand Increasing in The Genotyping Market?

There is an increase in the demand for genotyping. This is due to rise in importance of precision medicine, surge in genetic research, and increase in awareness of inherited diseases. Shift toward personalized or precision medicine also fosters the growth of the market. Healthcare providers are using genetic information to tailor treatments based on the genetic profile of an individual. Genotyping enables clinicians to identify specific gene variations that influence disease risk or drug response. This improves treatment effectiveness and reduces adverse drug reactions.

Surge in prevalence of chronic and genetic disorders is boosting the growth of the market. Genotyping is used to assess disease susceptibility and guide preventive interventions. This trend aligns with the global move toward proactive healthcare strategies.

Technological advancements in genotyping also fosters the rise in demand. Next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies have made genotyping faster, accurate, and affordable. These improvements reduce testing costs and increase accessibility for both clinical and research applications. Government funding for genomics research and large-scale population sequencing projects further boosts the market demand. Many countries are investing in national genomics initiatives to strengthen healthcare infrastructure and scientific research capabilities.

We offer customized report as per your requirement

Recent Development

• In July 2023, QIAGEN announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
• In June 2022, Roche announced the launch of a human papillomavirus (HPV) self-sampling solution in countries accepting the CE mark. This new solution enables a patient to privately collect her sample for HPV screening while at a healthcare facility, following instructions provided by a healthcare worker. The clinically-validated vaginal sample is analyzed with the Roche cobas HPV test on a Roche molecular instrument.

The report provides a detailed analysis of these key players in the global genotyping market. These players have adopted different strategies such as expansion, product launch, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry:  

Iodine Deficiency Drug Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Injectable Cement Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Orthodontic Headgear Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Digital Radiology/Radiography Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Hearing Care Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2030

Intravenous (IV) Therapy and Vein Access Market – Global Opportunity Analysis and Industry Forecast, 2024-2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int’l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

[email protected]

Web: https://www.alliedmarketresearch.com  

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/genotyping-market-to-reach-61-6-billion-by-2033-globally-at-13-8-cagr-allied-market-research-302688654.html

Disclaimer: The above press release comes to you under an arrangement with PR Newswire. UK Newshour takes no editorial responsibility for the same.